Patent ID: 7598256

Claim:
A pharmaceutical composition, comprising a compound of formula (I): wherein R 1 is selected from the group consisting of alkyl, alkoxy, aryloxy, alkylthio, arylthio, aryl, halogen, CN, NR 7 R 8 , NR 6 COR 7 , NR 6 CONR 7 R 8 , NR 6 CO 2 R 9 , and NR 6 SO 2 R 9 ; R 2 is an aryl attached via an unsaturated ring carbon of said aryl group; R 3 and R 4 are independently selected from the group consisting of H, alkyl, halogen, alkoxy, alkylthio, CN, and NR 7 R 8 ; R 5 is selected from the group consisting of H, acyclic alkyl, COR 6 , CONR 7 R 8 , CONR 6 NR 7 R 8 , CO 2 R 9 , and SO 2 R 9 ; R 6 , R 7 , and R 8 are independently selected from the group consisting of H, alkyl, and aryl, or where R 7 and R 8 are in an NR 7 R 8 group R 7 and R 8 may be linked to form a heterocyclic group, or where R 6 , R 7 , and R 8 are in a (CONR 6 NR 7 R 8 ) group, R 6 and R 7 may be linked to form a heterocyclic group; and R 9 is selected from alkyl and aryl, or a pharmaceutically acceptable salt thereof, in combination with a pharmaceutically acceptable carrier or excipient.